(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.21%) $11.02
(0.56%) $0.808
(-0.95%) $93.01
Live Chart Being Loaded With Signals
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service...
Stats | |
---|---|
Today's Volume | 100.00 |
Average Volume | 42.00 |
Market Cap | 26.03B |
EPS | $0.149 ( 2023-09-29 ) |
Last Dividend | $0.0480 ( 2023-08-16 ) |
Next Dividend | $0 ( N/A ) |
P/E | 29.50 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Douglas Robert Andrew | Buy | 0 | |
2023-11-27 | Sandercock Brett | Sell | 3 000 | ResMed Common Stock |
2023-11-22 | Rider Michael J | Sell | 72 | ResMed Common Stock |
2023-11-16 | Burt Carol | Buy | 1 768 | ResMed Common Stock |
2023-11-16 | Farrell Michael J. | Buy | 3 462 | ResMed Common Stock |
INSIDER POWER |
---|
17.57 |
Last 97 transactions |
Buy: 212 786 | Sell: 177 067 |
ResMed Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ResMed Inc. Financials
Annual | 2023 |
Revenue: | $4.22B |
Gross Profit: | $2.36B (55.78 %) |
EPS: | $0.610 |
Q4 | 2023 |
Revenue: | $1.12B |
Gross Profit: | $617.39M (55.02 %) |
EPS: | $0.160 |
Q3 | 2023 |
Revenue: | $1.12B |
Gross Profit: | $617.75M (55.31 %) |
EPS: | $0.150 |
Q2 | 2023 |
Revenue: | $1.03B |
Gross Profit: | $579.72M (56.08 %) |
EPS: | $0.160 |
Financial Reports:
No articles found.
ResMed Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0440 (N/A) |
$0.0440 (N/A) |
$0.0440 (N/A) |
$0.0440 (N/A) |
$0.0480 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.170 | 2013-05-17 |
Last Dividend | $0.0480 | 2023-08-16 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 28 | -- |
Total Paid Out | $1.168 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.24 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.32 | |
Div. Directional Score | 8.19 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
VTKLY | Ex Dividend Knight | 2023-07-20 | Semi-Annually | 0 | 0.00% | |
MALRY | Ex Dividend Junior | 2023-09-07 | Annually | 0 | 0.00% | |
CNLPL | Ex Dividend Knight | 2023-09-07 | Quarterly | 0 | 0.00% | |
SLVYY | Ex Dividend Knight | 2023-05-15 | Semi-Annually | 0 | 0.00% | |
HDELY | Ex Dividend Knight | 2023-05-12 | Annually | 0 | 0.00% | |
ASAZY | Ex Dividend Knight | 2023-04-27 | Annually | 0 | 0.00% | |
NHMD | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
DANOY | Ex Dividend Junior | 2023-05-05 | Annually | 0 | 0.00% | |
TDCB | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
HYPMY | Ex Dividend Knight | 2023-07-06 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.91 | 8.87 | [0 - 0.5] |
returnOnAssetsTTM | 0.129 | 1.200 | 5.70 | 6.84 | [0 - 0.3] |
returnOnEquityTTM | 0.212 | 1.500 | 8.75 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.304 | -1.000 | 6.96 | -6.96 | [0 - 1] |
currentRatioTTM | 3.11 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.230 | 0.800 | 7.47 | 5.98 | [0.8 - 2.5] |
cashRatioTTM | 0.275 | 1.500 | 9.58 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.202 | -1.500 | 6.64 | -9.96 | [0 - 0.6] |
interestCoverageTTM | -19.43 | 1.000 | -8.31 | -8.31 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.733 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.641 | 2.00 | 9.68 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.310 | -1.500 | 8.76 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.569 | 1.000 | 3.84 | 3.84 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.262 | 1.000 | 6.77 | 6.77 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.776 | 1.000 | 6.80 | 6.80 | [0.2 - 2] |
assetTurnoverTTM | 0.631 | 0.800 | 9.12 | 7.30 | [0.5 - 2] |
Total Score | 11.05 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 31.50 | 1.000 | 6.92 | 0 | [1 - 100] |
returnOnEquityTTM | 0.212 | 2.50 | 9.20 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.641 | 2.00 | 9.79 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.986 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.733 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.304 | 1.500 | 6.96 | -6.96 | [0 - 1] |
pegRatioTTM | -3.78 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.248 | 1.000 | 6.31 | 0 | [0.1 - 0.5] |
Total Score | 5.32 |
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators